GeneDx Holdings Corp. aktie
WGS
Pre-market$53.13+1.13 (+2.17%)
Pre-Market:$52.96-0.17 (-0.32%)
Laddar diagram...
GeneDx Holdings Corp.
Market Cap
$1,577,324,928
Öppning51.08
Högsta53.16
Lägsta49.49
Volym1.05M
P/EN/A
Börsvärde1.58B
52 veckors högsta170.87
52 veckors lägsta32.21
Genomsnittlig volym1.19M
UtdelningN/A
Beta2.07
EPS-2.66
Om GeneDx Holdings Corp. aktie
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Företagsinformation
Börs: NasdaqGS (NMS)
Sektor: Sundhed
Industri: Diagnostik og forskning
Adress:
North Tower
06902 Stamford, United States
06902 Stamford, United States
Telefon: + 888 729 1206
Hemsida: https://www.genedx.com
Analytikernas aktierekommendationer
Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.
Anbefaling:1.11 - Stærk køb
Lägsta kursmål
50.00
↓ 5.9%
Genomsnittligt kursmål
77.00
↑ 44.9%
Median kursmål
75.00
↑ 41.2%
Högsta kursmål
100.00
↑ 88.2%